Transducing-Like Enhancer of Split 1: A Potential Immunohistochemical Marker for Glomus Tumor

• Published in: The American journal of dermatopathology Vol. 39; no. 7; p. 524
• Main Authors: Bozdogan, Nazan, Dilek, Gulay B, Benzer, Emine, Karadeniz, Mujde, Bozdogan, Onder
• Format: Journal Article
• Language: English
• Published: United States 01.07.2017
• Subjects: Adult; Aged; Biomarkers, Tumor - analysis; Female; Glomus Tumor - diagnosis; Humans; Male; Middle Aged; Repressor Proteins - analysis; Repressor Proteins - biosynthesis
• ISSN: 1533-0311
• DOI: 10.1097/DAD.0000000000000705

Glomus tumors (GTs) are rare, perivascular soft tissue tumors. Although GTs are usually found in the subcutaneous tissue, they may be detected in extracutaneous sites and mucosal areas. Transducing-like enhancer of split 1 (TLE1) is a highly useful immunohistochemical marker, which basically helps in differential diagnosis of synovial sarcoma. Based on a coincidental detection of TLE1 in one GT case, we studied 26 additional GT cases to establish the importance and distribution of TLE1 in GTs. Of 24 subcutaneous GTs, 22 (91.6%) were positive for TLE1 antibody and the remaining 2 mucosal GTs were negative. Of the 22 positive cases, 10 showed strong nuclear positivity. There was no difference between the subtypes of the GTs. Although TLE1 expression is significantly correlated to SS18 (SYT) rearrangements in synovial sarcomas, the fluorescence in situ hybridization analyses of the GTs showed no evidence of translocation involving this locus. TLE1 is a potential immunohistochemical marker for GTs, but further studies are required to confirm this finding.